|6.38||-0.16 / -2.45%|
As of 3:59pm ET
|6.35||-0.03 / -0.47%|
The 1 analysts offering 12-month price forecasts for Oramed Pharmaceuticals Inc have a median target of 27.00, with a high estimate of 27.00 and a low estimate of 27.00. The median estimate represents a +323.20% increase from the last price of 6.38.
The current consensus among 1 polled investment analysts is to Buy stock in Oramed Pharmaceuticals Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.